Increased mTORC1 activation in salivary gland B cells and T cells from patients with Sjögren's syndrome: mTOR inhibition as a novel therapeutic strategy to halt immunopathology?
Sofie L M BloklandMaarten R HillenCatharina G K WichersMaili ZimmermannAike A KruizeTimothy R D J RadstakeJasper C A BroenJoel A G van RoonPublished in: RMD open (2019)